胰岛素样生长因子家族在子宫内膜癌中的作用

摘要/Abstract

摘要：胰岛素样生长因子（IGF）在子宫内膜癌（EC）组织中表达和活性增加，不仅介导雌激素对EC的促进作用，也可增加代谢相关EC形成的风险，并在EC的侵袭、转移、耐药等方面发挥推动作用。抑制IGF有望成为EC治疗的新方向。

高无怨，王丽华. 胰岛素样生长因子家族在子宫内膜癌中的作用[J]. 国际肿瘤学杂志, 2017, 44(10): 794-797.

Gao Wuyuan, Wang Lihua. Role of insulinlike growth factors family in endometrial cancer[J]. Journal of International Oncology, 2017, 44(10): 794-797.

［1］ Bruchim I, Sarfstein R, Werner H. The IGF hormonal network in endometrial cancer: functions, regulation, and targeting approaches［J］. Front Endocrinol (Lausanne), 2014, 5: 76. DOI: 10.3389/fendo.2014.00076. ［2］ Paveli′c J, Radakovi′c B, Paveli′c K. Insulinlike growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6phosphate) in endometrial adenocarcinoma［J］. Gynecol Oncol, 2007, 105(3): 727735. ［3］陈红漫, 赵振苓, 袁莉, 等. IGF1和COX2在子宫内膜癌中的表达及其临床意义［J］. 天津医药, 2013, 1(1): 1821. DOI: 10.3969/j.issn.02539896.2013.01.006. ［4］ Mendivil A, Zhou C, Cantrell LA, et al. AMG 479, a novel IGF1R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways［J］. Reprod Sci, 2011, 18(9): 832841. DOI: 10.1177/1933719111398501. ［5］ Wang Y, Hua S, Tian W, et al. Mitogenic and antiapoptotic effects of insulin in endometrial cancer are phosphatidylinositol 3kinase/Akt dependent［J］. Gynecol Oncol, 2012, 125(3): 734741. DOI: 10.1016/j.ygyno.2012.03.012. ［6］ Wang CF, Zhang G, Zhao LJ, et al. Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth［J］. PLoS One, 2013, 8(8): e69001. DOI: 10.1371/journal.pone.0069001. ［7］ Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review［J］. Cancer Epidemiol Biomarkers Prev, 2002, 11(12): 15311543. ［8］ Gielen SC, Hanekamp EE, Blok LJ, et al. Steroidmodulated proliferation of human endometrial carcinoma cell lines: any role for insulinlike growth factor signaling?［J］. J Soc Gynecol Investig, 2005, 12(1): 5864. DOI: 10.1016/j.jsgi.2004.08.003. ［9］ De Marco P, Bartella V, Vivacqua A, et al. Insulinlike growth factorⅠ regulates GPER expression and function in cancer cells［J］. Oncogene, 2013, 32(6): 678688. DOI: 10.1038/onc.2012.97. ［10］ Xie BY, Lv QY, Ning CC, et al. TET1GPERPI3K/AKT pathway is involved in insulindriven endometrial cancer cell proliferation［J］. Biochem Biophys Res Commun, 2017, 482(4): 857862. DOI: 10.1016/j.bbrc.2016.11.124. ［11］ Zhan Y, Wang J, Ma Y, et al. Serum insulinlike, growth factor binding proteinrelated protein 1 (IGFBPrP1) and endometrial cancer risk in Chinese women［J］. Int J Cancer, 2013, 132(2): 411416. DOI: 10.1002/ijc.27622. ［12］ Makker A, Goel MM. Tumor progression, metastasis, and modulators of epithelialmesenchymal transition in endometrioid endometrial carcinoma: an update［J］. Endocr Relat Cancer, 2016, 23(2): R85R111. DOI: 10.1530/ERC150218. ［13］ Pengchong H, Tao H. Expression of IGF1R, VEGFC and D240 and their correlation with lymph node metastasis in endometrial adenocarcinoma［J］. Eur J Gynaecol Oncol, 2011, 32(6): 660664. ［14］ Gribben L, Baxter RC, Marsh DJ. Insulinlike growth factor binding protein3 inhibits migration of endometrial cancer cells［J］. Cancer Lett, 2012, 317(1): 4148. DOI: 10.1016/j.canlet.2011.11.011. ［15］万璟, 李小毛, 舒珊荣, 等. 慢病毒介导的靶向沉默胰岛素样生长因子1型受体的siRNA对人子宫内膜癌细胞迁移和侵袭能力的影响［J］. 中国病理生理杂志, 2012, 28(8): 13521357. DOI: 10.3969/j.issn.10004718.2012.08.002. ［16］ Zaino RJ, Brady WE, Todd W, et al. Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study［J］. Int J Gynecol Pathol, 2014, 33(6): 543553. DOI: 10.1097/PGP.0000000000000177. ［17］ Xie Y, Wang YL, Yu L, et al. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells［J］. J Steroid Biochem Mol Biol, 2011, 126(35): 113120. DOI: 10.1097/PGP.0000000000000177. ［18］ Pant A, Lee II, Lu Z, et al. Inhibition of AKT with the orally active allosteric AKT inhibitor, MK2206, sensitizes endometrial cancer cells to progestin［J］. PLoS One, 2012, 7(7): e41593. DOI: 10.1371/journal.pone.0041593. ［19］顾超. PI3K/Akt信号通路调控孕激素对子宫内膜癌的作用及分子机制研究［D］. 上海: 复旦大学, 2011. ［20］ Bitelman C, Sarfstein R, Sarig M, et al. IGF1Rdirected targeted therapy enhances the cytotoxic effect of chemotherapy in endometrial cancer［J］. Cancer Lett, 2013, 335(1): 153159. DOI: 10.1016/j.canlet.2013.02.009. ［21］ Zhang Y, Li MX, Wang H, et al. Metformin downregulates endometrial carcinoma cell secretion of IGF1 and expression of IGF1R［J］. Asian Pac J Cancer Prev, 2015, 16(1): 221225. ［22］ Shafiee MN, Malik DA, Yunos RI, et al. The effect of Metformin on endometrial tumorregulatory genes and systemic metabolic parameters in polycystic ovarian syndrome—a proofofconcept study［J］. Gynecol Endocrinol, 2015, 31(4): 286290. DOI: 10.3109/09513590.2014.989982. ［23］ Xie Y, Wang JL, Ji M, et al. Regulation of insulinlike growth factor signaling by metformin in endometrial cancer cells［J］. Oncol Lett, 2014, 8(5): 19931999. DOI: 10.3892/ol.2014.2466. ［24］ Markowska A, Pawaowska M, Filas V, et al. Does Metformin affect ER, PR, IGF1R, betacatenin and PAX2 expression in women with diabetes mellitus and endometrial cancer?［J］. Diabetol Metab Syndr, 2013, 5: 76. DOI: 10.1186/17585996576. ［25］ Shafiee MN, Khan G, Ariffin R, et al. Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help?［J］. Gynecol Oncol, 2014, 132(1): 248253. DOI: 10.1016/j.ygyno.2013.10.028. ［26］ Shafiee MN, Seedhouse C, Mongan N, et al. Upregulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer［J］. Mol Cell Endocrinol, 2016, 424: 94101. DOI: 10.1016/j.mce.2016.01.019. ［27］ AttiasGeva Z, Bentov I, Ludwig DL, et al. Insulinlike growth factorⅠ receptor (IGFIR) targeting with monoclonal antibody cixutumumab (IMCA12) inhibits IGFⅠ action in endometrial cancer cells［J］. Eur J Cancer, 2011, 47(11): 17171726. DOI: 10.1016/j.ejca.2011.02.019. ［28］ AttiasGeva Z, Bentov I, Fishman A, et al. Insulinlike growth factorⅠ receptor inhibition by specific tyrosine kinase inhibitor NVPAEW541 in endometrioid and serous papillary endometrial cancer cell lines［J］. Gynecol Oncol, 2011, 121(2): 383389. DOI: 10.1016/j.ygyno.2011.01.008. ［29］ Shu S, Li X, Yang Y, et al. Inhibitory effect of siRNA targeting IGF1R on endometrial carcinoma［J］. Int Immunopharmacol, 2011, 11(2): 244249. DOI: 10.1016/j.intimp.2010.11.031. ［30］ Sun J, Li W, Sun Y, et al. A novel antisense long noncoding RNA within the IGF1R gene locus is imprinted in hematopoietic malignancies［J］. Nucleic Acids Res, 2014, 42(15): 95889601. DOI: 10.1093/nar/gku549. ［31］ Ghazal S, McKinnon B, Zhou J, et al. H19 lncRNA alters stromal cell growth via IGF signaling in the endometrium of women with endometriosis［J］. EMBO Mol Med, 2015, 7(8): 9961003. DOI: 10.15252/emmm.201505245. ［32］ Dong S, Qu X, Li W, et al. The long noncoding RNA, GAS5, enhances gefitinibinduced cell death in innate EGFR tyrosine kinase inhibitorresistant lung adenocarcinoma cells with widetype EGFR via downregulation of the IGF1R expression［J］. J Hematol Oncoly, 2015, 8: 43. DOI: 10.1186/s1304501501406. ［33］ Li Z, Wei D, Yang C, et al. Overexpression of long noncoding RNA, NEAT1 promotes cell proliferation, invasion and migration in endometrial endometrioid adenocarcinoma［J］. Biomed Pharmacother, 2016, 84: 244251. DOI: 10.1016/j.biopha.2016.09.008.

[1]	凡梦思, 陆雅萍, 闫莉.子宫内膜癌前哨淋巴结假阴性患者的临床病理特征分析[J]. 国际肿瘤学杂志, 2023, 50(5): 274-279.
[2]	杨洪娟, 孙云川, 何新颖, 毕建强, 肖丽.子宫内膜中肾样腺癌1例并文献复习[J]. 国际肿瘤学杂志, 2023, 50(4): 255-256.
[3]	吕璐, 孙鹏飞, 崔腾璐.子宫内膜癌颈部淋巴结转移综合治疗1例并文献复习[J]. 国际肿瘤学杂志, 2023, 50(11): 701-704.
[4]	李宁, 张玢琪.免疫检查点抑制剂在子宫内膜癌中的应用[J]. 国际肿瘤学杂志, 2022, 49(2): 125-128.
[5]	柳灿烔, 黄欣仪, 陈柳伊, 陈浩, 彭裕辉, 黄旭纯.胃癌患者血清胰岛素样生长因子结合蛋白7的水平及其诊断价值[J]. 国际肿瘤学杂志, 2022, 49(12): 724-728.
[6]	鲁历历, 孙鹏飞, 叶斌强.放化疗联合盐酸安罗替尼治疗复发性子宫内膜癌1例[J]. 国际肿瘤学杂志, 2022, 49(12): 766-768.
[7]	徐秋月, 马咸梅, 岳琦.基于分子分型的子宫内膜癌免疫治疗[J]. 国际肿瘤学杂志, 2022, 49(11): 700-704.
[8]	邓波儿, 孔为民.子宫内膜癌的表观遗传学研究进展[J]. 国际肿瘤学杂志, 2021, 48(3): 184-188.
[9]	何哲锋, 裴铁民, 孟庆辉.IGF2BP1与肿瘤[J]. 国际肿瘤学杂志, 2021, 48(2): 92-95.
[10]	黄于庭, 汪超.盐酸小檗碱联合表柔比星、顺铂对晚期子宫内膜癌的抗肿瘤效果[J]. 国际肿瘤学杂志, 2020, 47(9): 530-534.
[11]	王雪, 纪国欣, 纪超, 杨兴升.二甲双胍对合并2型糖尿病的Ⅰ型子宫内膜癌患者预后的影响[J]. 国际肿瘤学杂志, 2020, 47(7): 404-408.
[12]	赵小玲, 孔为民.二甲双胍在子宫内膜癌中的基础与临床研究现状[J]. 国际肿瘤学杂志, 2020, 47(7): 440-443.
[13]	周露秋, 刘先喜, 李艳, 毛熙光.Ⅰ型子宫内膜癌的预后危险因素分析[J]. 国际肿瘤学杂志, 2020, 47(6): 346-350.
[14]	罗春翠, 袁超燕, 陈庆芬.GOLPH3通过PI3K/AKT/GSK3β信号调控子宫内膜癌细胞的增殖与凋亡[J]. 国际肿瘤学杂志, 2020, 47(2): 65-69.
[15]	李美艳.HE4、OPN及uPA检测对子宫内膜癌患者诊断的临床意义[J]. 国际肿瘤学杂志, 2017, 44(5): 351-355.

胰岛素样生长因子家族在子宫内膜癌中的作用

Role of insulinlike growth factors family in endometrial cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

本文评价